[Flunarizine and dihydroergotamine in the treatment of migraine in children].
We administer during 6 months in randomised way dihydroergotamine or flunarizine to 50 children affects of classical or common migraine. A significative improvement was estimated in frequency, intensity and duration of their crisis in 87% with dihydroergotamine and 79% with flunarizine, without significative differences from one to other. Dihydroergotamine was specially effective in children with vegetative lability. The secondary effects, 12% with dihydroergotamine and 20% with flunarizine, were trivial and advantageous even, without the necessity of stop the treatment in not any case.
Lastra Martínez
L
L
Sección de Neuropediatría Hospital Nacional Marqués de Valdecilla, Facultad de Medicina, Universidad de Cantabria, Santander.
Herranz Fernández
J
J
Arteaga Manjón-Cabez
R
R
D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D004087:Dihydroergotamine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005444:Flunarizine / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics*; D010290:Parents
D004087:Dihydroergotamine; D005444:Flunarizine
Flunarizina o dihidroergotamina en el tratamiento de la migraña en la infancia. Estudio randomizado de 50 pacientes.